“Sglt2 Inhibitors And The Clinical Conundrum Of Heart Failure With Preserved Ejection Fraction”. Journal of Pharmaceutical Negative Results, Nov. 2022, pp. 2200-4, https://doi.org/10.47750/pnr.2022.13.S04.273.